The immunologists' debt to the chicken

British Poultry Science

Volumn 44, Issue 1, 2003, Pages 6-21

  Davison, T F ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AVES; GALLID HERPESVIRUS 2; GALLIFORMES; GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS; MAMMALIA;

VACCINE;

ANIMAL; ANIMAL MODEL; B LYMPHOCYTE; BURSA FABRICII; CHICK EMBRYO; CHICKEN; GENE CONVERSION; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BURSA OF FABRICIUS; CHICK EMBRYO; CHICKENS; GENE CONVERSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MODELS, ANIMAL; T-LYMPHOCYTES; VACCINES;

EID: 0038482160     PISSN: 00071668     EISSN: None     Source Type: Journal    
DOI: 10.1080/0007166031000085364     Document Type: Review

References (92)

1. ADELMANN, H.B. trans. (1942) The Embryological Treatises of Hieronymus Fabricius of Aquapendente, Ithaca, NY, Cornell University Press.
2. BAXENDALE, W. (1996) Current methods of delivery of poultry vaccines, in: DAVISON, T.F., MORRIS, T.R. & PAYNE, L.N. (Eds) Poultry Immunology, Poultry Science Symposium Series, Vol. 24: pp. 375-387 (Abingdon, Carfax Publishing).
3. BECKER, R.S. & KNIGHT, K.L. (1990) Somatic diversification of immunoglobulin heavy chain VDJ genes: evidence for somatic gene conversion in rabbits. Cell, 63: 987-997.
4. BOYLE, D.B. & HEINE, H.G. (1993) Recombinant fowlpox virus vaccine for poultry. Immunology and Cell Biology, 71: 391-397.
5. BRILES, W.E., MCGIBBON, W.H. & IRWIN, M.R. (1950) On multiple alleles affecting cellular antigens in the chicken. Genetics, 35: 633-640.
6. BUCKMASTER, A.E., SCOTT, S.D., SANDERSON, M.J., BOURSNELL, M.E.G., Ross, N.L.J. & BINNS, M.M. (1988) Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification. Journal of General Virology, 69: 2033-2042.
7. BUMSTEAD, N. (1996) Breeding for disease resistance, in: DAVISON, T.F., MORRIS, T.R. & PAYNE, L.N. (Eds) Poultry Immunology, Poultry Science Symposium Series, Vol. 24, pp. 405-415 (Abingdon, Carfax Publishing).
8. BUMSTEAD, N. (1998) Genomic mapping of resistance to Marek's disease. Avian Pathology, 27: S78-S81.
9. BURNET, M. (1971) Cellular Immunology, (Cambridge, Cambridge University Press).
10. CALNEK, B.W., SCHAT, K.A., PECKHAM, M.C. & FABRICANT, J. (1983) Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Diseases, 16: 954-957.
11. CHANG, H.C., LIN, T.L. & WU, C.C. (2002) DNA-mediated vaccination against infectious bursal disease in chickens. Vaccine, 20: 328-335.
12. CHETTLE, N.J. & WYETH, P.J. (1989) Failure of maternally-derived infectious bursal disease antibodies to serotypes 1 and 2 to protect against heterologous virus. British Veterinary Journal, 145: 165-169.
13. CHURCHILL, A.E. & BIGGS, P.M. (1967) Agent of Marek's disease in tissue culture. Nature, 215: 528-530.
14. CHURCHILL, A.E., PAYNE, L.N. & CHUBB, R.C. (1969) Immunisation against Marek's disease using a live attenuated virus. Nature, 221: 744-747.
15. COOPER, M.D., PETERSON, R.D.A. & GOOD, R.A. (1965) Delineation of the thymic and bursal lymphoid systems in the chicken. Nature, 205: 143-147.
16. DAVISON, T.F. (1996) Cell-mediated immunity: effector functions, in: DAVISON, T.F., MORRIS, T.R. & PAYNE, L.N. Poultry Immunology, Poultry Science Symposium Series, Vol. 24, pp. 115-134, (Abingdon, Carfax Publishing).
17. DE KRUIF, P. (1953) Microbe Hunters (New York, Harcourt, Brace and World).
18. DIGBY, M.R. & LOWENTHAL, J.W. (1995) Cloning and expression of chicken interferon gamma gene. Journal of Interferon and Cytokine Research, 15: 939-945.
19. DOHERTY, P. & ZINKERNAGEL, R. (1975) Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature, 256: 50-52.
20. FODOR, I., HORVATH, E., FODOR, N., NAGY, E., RECENDORSH, A., VAKARIA, V.N. & DUBE, S.K. (1999) Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens. Acta Veterinaria Hungarica, 47: 481-492.
21. GANDON, S., MACKINNON, M.J., NEE, S. & READ, A.F. (2001). Imperfect vaccines and the evolution of pathogen virulence. Nature, 414: 751-755.
22. GILDERSLEEVE, R.P., HOYLE, C.M., MILES, A.M., MURRAY, D.L., RICKS, C.A., SECREST, M.N., WILIAMS, C.J. & WOMACK, C.L. (1993) Developmental performance of an egg injection machine for administration of Marek's disease vaccine. Journal of Applied Poultry Research, 2: 337-346.
23. GLICK, B. (1987) How it all began: the continuing story of the bursa of Fabricius, in: TOIVANEN, A. & TOIVANEN, P. (Eds) Avian Immunology: Basis and Practice, Vol. 1, pp. 1-7 (Boca Raton, FL, CRC Press).
24. GLICK, B., CHANG, T.S. & JAAP, R.G. (1956) The bursa of Fabricius and antibody production. Poultry Science, 35: 224-225.
25. GOWANS, J. (1959) The life history of lymphocytes. British Medical Bulletin, 15: 10-53.
26. ISAACS, A. & LINDENMANN, J. (1957) Virus interference. I. The interferon. Proceedings of the Royal Society of London, 147: 258-267.
27. JANEWAY, C.A. & TRAVERS, P. (2001) Immunobiology: The Immune System in Health and Disease, 4th edn (London, Current Biology Ltd).
28. KAUFMAN, J. (2000) The simple chicken major histocompatability complex: life and death in the face of pathogens and vaccines. Philosophical Transactions of the Royal Society of London B, 355: 1077-1084.
29. KAUFMAN, J. & SALOMONSEN, J. (1997) The "minimal essential MHC" revisited: both peptide-binding and cell surface expression level of MHC molecules and polymorphisms selected by pathogens in chicken. Hereditas, 127: 67-73.
30. KAUFMAN, J. & VENUGOPAL, K. (1998) The importance of MHC for Rous sarcoma virus and Marek's disease virus-some Payne-ful considerations. Avian Pathology, 27: S82-S87.
31. KAUFMAN, J., JACOB, J., SHAW, I., WALKER, B.A., MILNE, S., BECK, S. & SALOMONSEN, J. (1999a) Gene organization determines evolution of function in the chicken MHC. Immunological Reviews, 167: 101-117.
32. KAUFMAN, J., MILNE, S., GÖBEL, T.W.F., WALKER, B.A., JACOB, J.P., AUFFRAY, C., ZOOROB, R. & BECK, S. (1999b) The chicken B locus is a minimal essential major histocompatability complex. Nature, 401: 923-925.
33. KAUFMAN, J., VÖLK, H. & WALLNY, H.-J. (1995) The "minimal essential Mhc" and an "unrecognized Mhc": two extremes in selection for polymorphism. Immunological Reviews, 143: 63-88.
34. KODIHALLI, S., HAYNES, J.R., ROBINSON, H.L. & WEBSTER, R.G. (1997) Cross protection among lethal H2N2 influenza viruses induced by DNA vaccine to the haemagglutinin. Journal of Virology, 71: 3391-3396.
35. KREIG, A.M., AE-KYUNG, Y., SCHORR, J. & DAVIS, H.L. (1998) The role of CpG dinucleotides in DNA vaccines. Trends in Microbiology, 6: 23-26.
36. KREIG, A.M. (2000) The role of CpG motifs in innate immunity. Current Opinion in Immunology, 12: 35-43.
37. KREMPIEN, U., REDMANN, I. & JUNGWIRTH, C. (1985) Purification of chicken interferon with zinc chelate affinity chromatography and sodium dodecylsulfate-polyacrylamide gel electrophoresis. Journal of Interferon Research, 5: 209-214.
38. LEE, L.F., POWELL, P.O.C., RENNIE, M., ROSS, L.J.N. & PAYNE, L.N. (1981) Nature of genetic resistance to Marek's disease in chickens. Journal of the National Cancer Institute, 166: 789-796.
39. MAREK, J. (1907) Multiple Nerventzündung (Polyneuritis) bei Hühnern. Deutsche Tierärzzeitung Wochenschrift, 15; 417-421.
40. MAST, J. & GODDEERIS, B.M. (1999) Development of immunocompetence of broiler chickens. Veterinary Immunology and Immunopathology, 70: 245-256.
41. L gene rearrangement involves deletion of a circular episome and addition of single non-random nucleotides to both coding segments. Cell, 56: 785-791.
42. MCCORMACK, W.T. & THOMPSON, C.B. (1990) Somatic diversification of the chicken immunoglobulin light chain gene. Advances in Immunology, 48: 41-67.
43. MURPHY, J.B. (1914a) Studies in tissue specificity. II. The ultimate fate of mammalian tissue implanted in the chick embryo. Journal of Experimental Medicine, 19: 181-186.
44. MURPHY, J.B. (1914b) Studies in tissue specificity. III. Factors of resistance to heteroplastic tissue-grafting. Journal of Experimental Medicine, 19: 513-522.
45. MURPHY, J.B. (1916) The effect of adult chicken organ graft on the chick embryo. Journal of Experimental Medicine, 24: 1-10.
46. MURPHY, J.B. (1926) The lymphocyte in resistance to tissue grafting, malignant disease and tuberculous infection. Monographs of the Rockefeller Institute for Medical Research, 21: 1-30.
47. NAZERIAN, K., LEE, L.F., YANAGIDA, N. & OGAWA, R. (1992) Protection against Marek's disease by a fowlpox recombinant expressing glycoprotein B of Marek's disease virus. Journal of Virology, 66: 1402-1406.
48. PAPPENHEIMER, A.M., DUNN, L.C. & CONE, V. (1926) A study of fowl paralysis (neuro-lymphomatosis gallinarum). Storrs Agricultural Experimental Station Bulletin, No. 143, 186-290.
49. PAPPENHEIMER, A.M., DUMM, L.C. & CONE, V. (1929) Studies on fowl paralysis (neuro-lymphomatosis gallinarum). I. Clinical features and pathology. Journal of Experimental Medicine, 49: 87-102.
50. PASTEUR, L. (1880) De l'atténuation du virus du choléra des poules. Comptes Rendus Academie de Sciences, Paris, 91: 673-680.
51. PLACHY, J., PINK, J.R.L. & HALA, K. (1992) Biology of the chicken MHC (B complex). Critical Reviews in Immunology, 12: 47-79.
52. POWELL, P.C. (1986) Marek's disease-a world poultry problem. World's Poultry Science Journal, 42: 205-218.
53. PURCHASE, H.G. (1973) Control of Marek's disease by vaccination. World's Poultry Science Journal, 29: 238-250.
54. RATCLIFFE, M. & PARAMITHIOTIS, E. (1990) The end can justify the means. Seminars in Immunology, 2: 217-226.
55. REYNARD, C.A., ANQUEZ, V., DAHAN, A. & WEILL, J.C. (1985) A single rearrangement event generates most of the chicken immunoglobulin light chain diversity. Cell, 40: 283-291.
56. REYNARD, C.A., ANQUEZ, V., DAHAN, A. & WEILL, J.C. (1987) The hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell, 48: 379-388.
57. H gene of the chicken with a high incidence in the D region. Cell, 59: 171-183.
58. RISPENS, B.H., VAN VLOTEN, H., MAAS, H.J. & HENDRICK, J.L. (1972a) Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus strain (CVI988) and its use in laboratory vaccination trials. Avian Diseases, 16: 108-125.
59. RISPENS, B.H., VAN VLOTEN, H., MASTENBROEK, N., MAAS, H.J. & HENDRICK, J.L. (1972b) Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI988) of Marek's disease virus. Avian Diseases, 16: 126-138.
60. SAKAGUCHI, M., NAKAMURA, H., SONODA, K., HAMADA, F. & HIRAI, K. (1996) Protection of chicken from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine, 14: 747-752.
61. SCHAT, K.A. & KAISER, P. (1997) Avian cytokines, in: SCHIJNS, V.E.C.J. & HORZINEK, M.C. (Eds) Cytokines in Veterinary Medicine, pp. 289-300 (Wallingford, CAB Press).
62. SCHAT, K.A. & MARKOWSKI-GRIMSRUD, C.J. (2001) Immune responses to Marek's disease virus, in: HIRAI, K. (Ed) Marek's Disease, (Berlin, Springer).
63. SEKELLICK, M.J. & MARCUS, P.I. (1986) Induction of higher titer chicken interferon. Methods in Enzymology, 119: 115-125.
64. SEKELLICK, M.J., FERRANDINO, A.F. HOPKINS, D.A. & MARCUS, P.I. (1996) Chicken interferon gene: cloning, expression and analysis. Journal of Interferon Research, 14: 71-79.
65. SEO, S.H., WANG, L., SMITH, R. & COLLISSON, E.W. (1997) The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection. Journal of Virology, 71: 7889-7894.
66. SHARMA, J. (1981) Natural killer cells activity in chickens exposed to Marek's disease virus: inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens. Avian Diseases, 25: 882-893.
67. SHARMA, J. (1999) Introduction to poultry vaccines and immunity. Advances in Veterinary Medicine, 41: 481-494.
68. SHARMA, J.M. & BURMESTER, B.R. (1982) Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Diseases, 26: 134-149.
69. SHARMA, J. M. & OKAZAKI, W. (1981) Natural killer cells activity in chickens; target cell analysis and effect of antithymocyte serum on effector cells. Infection and Immunity, 31: 1078-1085.
70. SHARMA, J.M. & WITTER, R.L. (1983) Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination. Avian Diseases, 27: 453-463.
71. SHAW, I. & DAVISON, T.F. (2000) Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titre of challenge virus and chicken genotype. Vaccine, 18: 3230-3241.
72. SILVERSTEIN, A.M. (2001) The lymphocyte in immunology: from James B. Murphy to James L. Gowans. Nature Immunology, 2: 569-571.
73. SIMONSEN, M. (1957) The impact of the developing embryo and newborn animal of adult homologous cells. Acta Pathologica Microbiologica Scandinavica, 40: 480-500.
74. SIMONSEN, M. (1985) Graft-versus-host reactions: the history that never was, and the way things happened to happen. Immunological Reviews, 88: 5-25.
75. SONG, K.D., LILLEHOJ, H.S., CHOI, K.D., YUN, C.H., PARCELLS, M.S., HUYNH, J.T. & HAN, J.Y. (2001) A DNA vaccine encoding a conserved Eimeria protein induces protective immunity against live Eimeria acervulina challenge. Vaccine, 19: 243-252.
76. STAEHELI, P., PUEHLER, F., SCHNEIDER, K., GÖBEL, T.W. & KASPERS, B. (2001) Cytokines of birds: conserved functions - a largely different look. Journal of Interferon and Cytokine Research, 21: 993-1010.
77. SZENBERG, A. & WARNER, N.L. (1962) Dissociation of immunological responsiveness in fowls with a hormonally arrested development of lymphoid tissue. Nature, 194: 146.
78. TONEGAWA, S. (1983) Somatic generation of antibody diversity. Nature, 302: 575-583.
79. THOMPSON, C.B. & NIEMAN, P.E. (1987) Somatic diversification of the chicken immunoglobulin light chain gene is limited to the rearranged variable region gene segment. Cell, 48: 369-378.
80. TROWSDALE, J. (1995) "Both man and bird and beast" comparative organisation of the MHC genes. Immunogenetics, 41: 1-17.
81. WARNER, N.L. & SZENBERG, A. (1962) Effect of neonatal thymectomy on the immune response in the chicken. Nature, 196: 784-785.
82. WARNER, N. L. SZENBERG, A. & BURNETT, F.M. (1962) The immunological role of different lymphoid organs in the chicken. I. Dissociation of immunological responsiveness. Australian Journal of Experimental Biology and Medicine, 40: 373-388.
83. WHITTON, J. L., RODRIGUEZ, F., ZHANG, J. & HASSETT, D.E. (1999) DNA immunization: mechanistic studies. Vaccine, 17: 1612-1619.
84. WEILL, J. C. & REYNARD, C.A. (1987) The chicken B cell compartment. Science, 238: 1094-1098.
85. WITTER, R.L. (1987) New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses; comparative efficacy. Avian Diseases, 31: 751-765.
86. WITTER, R.L. (1996) Evolution of virulence of Marek's disease virus: evidence for a novel pathotype, in: Current Research in Marek's Disease, Proceedings of 5th International Symposium on Marek's Disease, East Lansing, MI, pp. 86-91.
87. WITTER, R.L. (1997) Increased virulence of Marek's disease virus field isolates. Avian Diseases, 41: 149-163.
88. WITTER, R.L. (2001) Protective efficacy of Marek's disease vaccines, in: HIRAI, K. (Ed) Marek's Disease, pp. 57-90 (Berlin, Springer).
89. WITTER, R.L., NAZERIAN, K., PURCHASE, H.G. & BURGOYNE, G.H. (1970) Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. American Journal of Veterinary Research, 31: 525-538.
90. WITTER, R.L., SHARMA, J.M. LEE, L.F., OPITZ, J.M. & HENRY, C.W. (1984) Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Diseases, 24: 210-232.
91. ZHANG, Y. & SHARMA, J.M. (2001) Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine. Avian Diseases, 45: 639-645.
92. ZINKERNAGEL, R.M. & DOHERTY, P. (1979) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction specificity, function and responsiveness. Advances in Immunology, 27: 52-177.